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E-mail address: ajit.sodhi@lycos.com (A. Sodhi).Many extracellular stimuli, e.g. microbial products, cytokines etc., result in the expression of induc-
ible nitric oxide synthase (iNOS) in macrophages. However, it is not known whether expression of
the iNOS gene in response to microbial products is a primary response of macrophages, or is the
result of paracrine/autocrine signalling induced by endogenous biomolecules that are synthesised
as a result of host cell–microbe interaction. In this paper we demonstrate that iNOS expression in
mouse peritoneal macrophages in response to bacterial peptidoglycan (PGN) is a secondary effect
requiring autocrine signalling of endogenously produced prostaglandin E2, and that PGN stimula-
tion is mandatory, but not sufﬁcient in itself, for induction of iNOS expression.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction duced by enzyme inducible nitric oxide synthase (iNOS). Expres-Peptidoglycan (PGN) is a major component of bacterial cell wall.
It is recognised by innate immune system as an infection signal.
Interaction of PGN with host immune cells starts a signal transduc-
tion cascade resulting in production of proinﬂammatory mediators
and development of immune response which ultimately leads to
pathogen clearance [1]. Tissue resident macrophages are one of
the ﬁrst cells to respond to infection and the signalling that starts
during this primary encounter plays important role in the develop-
ment of immune response [2]. Interaction of PGN with naïve mac-
rophages causes macrophages to change their physiology to
become activated macrophages. These activated macrophages play
important role in pathogen clearance [3,4]. Activated macrophages
differ from naïve macrophages in having different surface recep-
tors and secreted products and have enhanced cytotoxic and
immunogenic properties [1]. Nitric oxide is one such secreted
product of activated macrophages. It is produced early during
infection and has profound effect on immune response develop-
ment. Nitric oxide is an important molecule because of its proin-
ﬂammatory, cytotoxic as well as immunosuppressive effects
[5,6]. In macrophages nitric oxide in response to infection is pro-chemical Societies. Published by E
se; COX2, cyclooxygenase 2;sion of iNOS in macrophages is controlled by cytokines and
microbial products, primarily by transcriptional induction [7].
However, there are inconsistencies in the reports. According to
some reports nitric oxide is immediate product of macrophage
pathogen interaction, while some suggest that nitric oxide produc-
tion is the result of autocrine or paracrine signalling induced by
endogenous biomolecules which are synthesised as a result of host
cell-microbe interaction [8]. Some reports suggest cyclooxygenase
2 (COX2) mediated induction of iNOS, but these are either in cancer
cell lines that constitutionally express COX2 [9] or have shown the
effect of COX2 enzymatic product prostaglandin E2 (PGE2) on the
enzymatic activity of iNOS [10]. Most of the studies related to tran-
scriptional induction and expression of iNOS are with puriﬁed
gram negative bacterial cell wall component LPS and little is
known about mechanism of iNOS expression in response to gram
positive bacterial products like PGN. Although the high-output
NO pathway probably evolved to protect the host from infection,
suppressive effects on lymphocyte proliferation and damage to
other normal host cells confer upon iNOS the protective/destruc-
tive duality [11]. Therefore, studying its regulation at the primary
level of production will provide useful insight into the mechanisms
of various inﬂammatory disorders which are associated with
chronic enhanced level of iNOS activity.
We report here that induction of iNOS in mouse peritoneal mac-
rophages in response to PGN is a secondary effect due to autocrine
signalling of PGE2 which is secreted as a result of PGN simulation.
And in PGN stimulated macrophages it is the PGE2 which controlslsevier B.V. All rights reserved.
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the synthesis of COX2.2. Materials and methods
2.1. Mice
Inbred strains of BALB/c mice of either sex at 8–10 weeks of age
were used for obtaining peritoneal macrophages.
2.2. Cell culture and reagents
Macrophage monolayers were generated as described previ-
ously [12]. Macrophages were cultured in RPMI 1640 medium
supplemented with 10% fetal calf serum, penicillin (100 U/ml),
streptomycin (100 U/ml), gentamycin (20 lg/ml) in CO2 incubator
(5% CO2). RPMI 1640 medium, PGN (Staphylococcus aureus), PGE2,
TRI-reagent, L-NMMA, lipopolysaccharide (LPS), interferon c,
NS398, cycloheximide and most of the other reagents were ob-
tained from Sigma–Aldrich Chemicals, St. Louis, MO, USA. Fetal calf
serum was purchased from Biological Industries, Israel. PD98059,
SB202190, SP600125 were purchased from Calbiochem, La Jolla,
CA, USA. Polyclonal antibodies against iNOS protein, actin, HRP-
conjugated anti-rabbit and anti-goat IgGs and siRNA cocktails were
obtained from Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA.
One-step real time RT-PCR kit was from Qiagen, Hilden, Germany.
All the reagents were endotoxin-free as determined by the Limulus
amoebocyte lysate assay (sensitivity limit, 0.1 ng/ml).
2.3. Inhibitor studies
Macrophage monolayers were cultured in serum free medium
in 24 well culture plates (1  106cells/well) with SP600125
(20 lM) or PD98059 (50 lM) or SB202190 (5 lM) or NS398
(3 lM) or cycloheximide (10 lg/ml) for 30 min. After that mono-
layers were washed twice with warm incomplete medium and fur-
ther cultured in complete medium in presence or absence of
stimulants in CO2 incubator.
2.4. Real time RT-PCR analysis
Total RNA was isolated from the macrophages by TRI reagent
according to suppliers’ instructions. Real time RT-PCR was done
using single step real time RT-PCR kit in Bio-Rad iQ5 real time
PCR machine using SYBR Green detection protocol. Gene speciﬁc
primers were used for amplifying genes (Supplementary informa-
tion 1). Cycling conditions were as described (Supplementary
information 2). We used the comparative cycle threshold method
(DDCt method) for relative quantitation of gene expression [13].
Ct values were calculated by software automatically after comple-
tion of run. DDCt was calculated and used for calculation of Fold
increase in expression (Supplementary information 3).
2.5. Measurement of nitrite production
The concentration of nitrite, the stable end product of NO, in
culture supernatants was determined by Griess reaction [14]. Ni-
trite content was quantiﬁed by extrapolation from sodium nitrite
standard curve in each experiment.
2.6. Western blot analysis
The macrophage monolayers were washed with ice-cold phos-
phate-buffered saline containing 1 mM Na3VO4, lysed in 15 ll/
cm2 of lysis buffer (Supplementary information 4) for 20 min at4 C. The lysates were centrifuged at 15,000g for 20 min and the
supernatants were separated on 10% SDS–polyacrylamide gels.
The separated proteins (40 lg/lane) were transferred to a nitrocel-
lulose membrane (1 h at 100 V) using a Bio-Rad Mini transblotter
and membrane was blocked with 5% non-fat dry milk for 2 h at
room temperature and incubated with primary antibody for
1 h at room temperature and then with HRP labelled secondary
antibody for 1 h at room temperature. The blot was developed using
ECL reagent. Tomonitor equal loading of protein, western blot anal-
ysis using antibody directed against actin was performed.
2.7. siRNA transfection
Macrophage monolayers were cultured overnight in complete
medium and transfected with COX2 or iNOS siRNA cocktail or with
negative control scrambled siRNA sequence using Lipofectamine
2000 according to suppliers’ instructions (Supplementary informa-
tion 5). siRNA concentration used for transfection were 25 nM.
2.8. Statistical analysis
The statistical signiﬁcance of difference between the test groups
was analyzed by Student’s t-test (two-tailed). The error bars of the
values represent 95% conﬁdence interval.3. Results and discussion
3.1. iNOS expression in PGN stimulated peritoneal macrophages
Macrophage monolayers were stimulated for 1 and 3 h with
PGN and total RNA was checked for the presence of iNOS tran-
scripts using real time RT-PCR. Level of iNOS transcripts after 1 h
of stimulation was found to be same as compared to untreated
macrophages but it was nearly 9 times higher after 3 h of stimula-
tion (Fig. 1A). Cell culture supernatants and cell lysates were also
checked for the presence of nitrite and iNOS protein after 24 h of
PGN stimulation. Presence of iNOS in whole cell lysates and nitrite
in culture supernatants indicate the presence of active enzyme
after PGN stimulation (Fig. 1B and C). To address the time lag in
the transcription of iNOS gene after PGN stimulation and to check
for the requirement of any de novo protein synthesis for iNOS tran-
scription, macrophages were treated with eukaryotic protein syn-
thesis inhibitor cycloheximide and then stimulated with PGN for
3 h. No increase in iNOS mRNA level in PGN stimulated macro-
phages (pretreated with cycloheximide) as compared to control
cells was observed, indicating the requirement of de novo protein
synthesis for PGN mediated iNOS gene transcription (Fig. 1D).
3.2. PGN mediated COX2 expression in peritoneal macrophages
COX2 is an inducible enzyme found in macrophages and is
responsible for the production of prostaglandins [15]. Relationship
of COX2 and iNOS has been documented earlier [16] but it is not
clearly established that product of which enzyme is responsible
for the induction of other [17,18]. To investigate this, macrophages
were pretreated with cycloheximide and then stimulated with PGN
for 3 h, and checked for the presence of COX2 mRNA using real
time RT-PCR. Cycloheximide treated macrophages were found to
have signiﬁcantly enhanced COX2 mRNA level as compared to con-
trol cells (Fig. 2A), indicating that COX2 expression is primary ef-
fect of PGN stimulation. Time kinetics studies for the expression
of COX2 and iNOS also showed that COX2 expression precedes
iNOS expression (Fig. 2D and E).
PGN induced COX2 expression was not affected in macro-
phages treated with competitive inhibitor of iNOS, L-NMMA,
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Fig. 1. (A) Real time RT-PCR analysis of iNOS mRNA. Macrophages were stimulated for 1 or 3 h with Peptidoglycan (6 lg/ml) or LPS (100 ng/ml) + IFNc (1 ng/ml). Each bar
represents fold expression relative to untreated macrophages (control). Each bar represents the standard error of three independent experiments. (B) Western blot analysis of
iNOS protein after 24 h of stimulation. Lane 1: unstimulated macrophages; lane 2: PGN (6 lg/ml) stimulated macrophages; lane 3: LPS (100 ng/ml) + IFNc (1 ng/ml)
stimulated macrophages. (C) Measurement of NO production after 24 h of stimulation. Macrophages were treated with PGN or PGN + IFNc for 24 h and culture supernatant
was checked for the presence of nitrite using Griess assay. Each bar represents nitrite concentration (lM). (D) Real time RT-PCR analysis of iNOS mRNA. Macrophages were
stimulated with PGN or PGN + cycloheximide (10 lg/ml) for 3 h and checked for the presence of iNOS mRNA. Each bar represents fold expression relative to untreated
macrophages.
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Fig. 2. (A) Real time RT-PCR analysis of COX2 mRNA. Macrophages were stimulated with PGN or PGN+cycloheximide or LPS for 3 h and total RNA was checked for the
presence of COX2 mRNA. Each bar represents fold expression relative to untreated macrophages. (B) Western blot analysis of COX2 protein after 24 h of stimulation. Lane 1:
unstimulated macrophages; lane 2: PGN stimulated macrophages; lane 3: PGN + L-NMMA (500 lM) stimulated macrophages. (C) Griess assay for NO measurement.
Macrophages were treated with PGN or PGN + L-NMMA (500 lM) for 24 h and culture supernatant was checked for the presence of nitrite using Griess assay. Each bar
represents nitrite concentration (lM). (D) Time kinetic studies of COX2 and iNOS protein expression upon PGN stimulation. Lane 1: unstimulated macrophages; lane 2: PGN
stimulation 30 min; lane 3: PGN stimulation 1 h; lane 4: PGN stimulation 2 h; lane 5: PGN stimulation 3 h; lane 6: PGN stimulation 6 h. (E) Time kinetic studies of COX2 and
iNOS mRNA expression upon PGN stimulation. Macrophages were stimulated with PGN for 30 min, 1, 2, 3 and 6 h. mRNA was isolated and checked for the presence of COX2
and iNOS transcripts. Each bar represents fold expression relative to untreated macrophages.
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Fig. 3. (A) Real time RT-PCR analysis of COX2 and iNOS mRNA. Macrophages were stimulated with PGN or PGN + PD98059 (50 lM) or PGN + SP600125 (20 lM) or
PGN + SB202190 (5 lM) for 3 h and checked for the presence of iNOS and COX2 mRNA. Each bar represents fold expression relative to untreated macrophages. (B) Western
blot analysis of iNOS and COX2 protein after 24 h of stimulation. Lane 1: unstimulated macrophages; lane 2: PGN stimulated macrophages; lane 3: PGN + SP600125
stimulated macrophages; lane 4: PGN + SB202190 stimulated macrophages; lane 5: PGN + PD98059 stimulated macrophages. (C) Real time RT-PCR analysis of COX2 and iNOS
mRNA. Macrophages were stimulated with PGN or PGN + NS398 (3 lM) for 3 h and checked for the presence of iNOS and COX2 mRNA. Each bar represents fold expression
relative to untreated macrophages. (D) Western blot analysis of iNOS and COX2 protein after 24 h of stimulation. Lane1: unstimulated macrophages; lane 2: PGN stimulated
macrophages; lane 3: PGN + IFNc stimulated macrophages; lane 4: PGN + NS398 treated macrophages. (E) Real time RT-PCR analysis of iNOS mRNA. Macrophages were
stimulated with PGN or PGN + SP600125 or PGN + SP600125 + PGE2 or PGE2 (50 nM) for 3 h and checked for the presence of iNOS mRNA. Each bar represents fold expression
relative to untreated macrophages. (F) Western blot analysis of iNOS protein after 24 h of stimulation. Lane 1: unstimulated macrophages (3347); lane 2: PGN stimulated
macrophages (12 308); lane 3: PGN + SP600125 treated macrophages (5562); lane 4: PGN + SP600125 + PGE2 treated macrophages (7191). Values in brackets indicate
integrated density values of spot densitometric analysis. (G) Western blot analysis of iNOS protein after 24 h of stimulation. Lane 1: unstimulated macrophages; lane 2: PGN
stimulated macrophages; lane 3: PGN + NS398 stimulated macrophages; lane 4:PGE2 stimulated macrophages; lane 5: PGN + NS398 + PGE2 stimulated macrophages. (H)
Real time RT-PCR analysis of iNOS and COX2 mRNA. COX2 or iNOS silenced macrophages were stimulated with PGN for 3 h and checked for the presence of COX2 an iNOS
mRNA. Each bar represents fold expression relative to untreated macrophages. (I) Western blot analysis of iNOS protein after 24 h of stimulation. Lane 1: unstimulated
macrophages; lane 2: PGN stimulated COX2 silenced macrophages; lane 3: PGN stimulated iNOS silenced macrophages; lane 4: PGN stimulated macrophages; lane 5: PGN
stimulated macrophages (negative control scrambled siRNA treated); lane6: PGN + NS398 stimulated macrophages.
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iated enhancement of PGE2 secretion has been reported previ-
ously, but this effect is due to enhanced enzymatic activity of
COX2 in presence of NO [19]. It is further observed that COX2
transcription is under negative feedback regulation by enzymatic
products of COX2 as macrophages treated with cycloheximide
and NS398, a speciﬁc inhibitor of COX2, showed enhanced level
of mRNA transcripts and COX2 protein respectively (Figs. 2A and
3D).
3.3. Effect of PGE2 on PGN mediated iNOS expression in macrophages
If iNOS expression upon PGN stimulation of macrophages is a
secondary effect because of autocrine signalling of endogenous
PGE2, then the pathways that are involved in PGN mediated
COX2 expression should also regulate iNOS expression after PGN
stimulation? The role of mitogen activated protein kinase (MAPK)
pathways on PGN mediated COX2 expression was also investi-
gated. Macrophages treated with JNK pathway inhibitor
SP600125 showed decreased expression of COX2 and iNOS at
mRNA as well as protein level (Fig. 3A and B). SP600125 treated
cells when stimulated with PGN in presence of exogenous PGE2
showed enhanced iNOS expression compared with PGN +
SP600125 treated cells (Fig. 3E and F). However, iNOS expression
was still low compared with PGN stimulated cells (Fig. 3F). Possible
explanation could be that PGN induced expression of COX2 as well
as prostaglandin receptors, which are present in very low amount
in naïve macrophages [20], is inhibited by JNK pathway inhibitor
hence exogenous PGE2 could not exert its full effect on SP600125
treated cells. Effect of NS398; a speciﬁc inhibitor of COX2, on
PGN mediated iNOS expression was also investigated. PGN stimu-
lation was not found to induce iNOS expression in NS398 treated
macrophages (Fig. 3C and D), however, iNOS expression was re-
stored when NS398 treated macrophages were stimulated with
PGN in presence of exogenous PGE2 (Fig. 3G). As NS398 does not
interfere with PGN signalling the level of iNOS was restored when
PGN + NS398 treated cells were stimulated with exogenous PGE2.
This indicates the possible role of PGN in inducing the expression
of the molecular machinery involved in PGE2 signalling (Fig. 3G).
We also checked PGN mediated iNOS expression in COX2 silenced
macrophages. Macrophages treated with COX2 speciﬁc siRNAs
showed downregulation in iNOS expression after PGN stimulation
at transcriptional and translational level (Fig. 3H and I). This con-
ﬁrms the role of COX2 as an upstream regulatory enzyme in mouse
peritoneal macrophages for the induction of iNOS expression upon
PGN stimulation. It supports our hypothesis that PGN mediated
iNOS expression in macrophages is a secondary effect because of
autocrine signalling of PGE2. PGN stimulation was found to be
essential for iNOS expression, as macrophages stimulated with
PGE2 alone did not show any induction in iNOS expression
(Fig. 3G). Absolute requirement of a microbial product for the
induction of iNOS seems to be a mechanism to prevent unneces-
sary damage to the tissues due to NO in absence of microbial infec-
tion. PGE2 is produced in many conditions that may not be
associated with any microbial infection. Given various anti-inﬂam-
matory and immunosuppressive effects of PGE2 [21] it is quite pos-
sible that some of themmay be due to the ability of PGE2 to induce
NO production, therefore studying these pathways better can pro-
vide a useful insight for the treatment of various conditions arising
due to immune dysregulation [22,23].4. Conclusion
It is demonstrated that PGN induced iNOS expression in mouse
peritoneal macrophages is a secondary effect in which PGE2 playsimportant role along with other autocrine/paracrine signalling
molecules like IFNc, TNFa, IFNb. However, PGE2 alone is not sufﬁ-
cient for induction of iNOS expression in mouse macrophages and
co-stimulation by microbial products e.g. PGN is an absolute
requirement.
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